GGrantIndex
← Search

Cancer Center Support Grant

$154,000P30FY2020CANIH

Wayne State University, Detroit MI

Investigators

Linked publications, trials & patents

Trial NCT06501040Trial NCT04479267Trial NCT04397679Trial NCT04266522Trial NCT04159896Trial NCT03875053Trial NCT03683420Trial NCT03456804Trial NCT03454529Trial NCT03453489Trial NCT03406858Trial NCT03252600Trial NCT03147885Trial NCT02824029Trial NCT02819024Trial NCT02723604Trial NCT02620865Trial NCT02568449Trial NCT02521090Trial NCT02520115Trial NCT02472275Trial NCT02470559Trial NCT02359019Trial NCT02178436Trial NCT02178163Trial NCT02173093Trial NCT02145078Trial NCT02094872Trial NCT02058706Trial NCT02037256Trial NCT01987596Trial NCT01958372Trial NCT01698658Trial NCT01504711Trial NCT01281163Trial NCT01175980Trial NCT01147016Trial NCT01116232Trial NCT01071564Trial NCT01051570Trial NCT01022138Trial NCT00984919Trial NCT00972023Trial NCT00942422Trial NCT00938626Trial NCT00935090Trial NCT00918762Trial NCT00914147Trial NCT00906503Trial NCT00903214Trial NCT00899665Trial NCT00897910Trial NCT00897741Trial NCT00897494Trial NCT00897247Trial NCT00890617Trial NCT00888654Trial NCT00769288Trial NCT00768118Trial NCT00717535Trial NCT00691015Trial NCT00559897Trial NCT00541099Trial NCT00527124Trial NCT00521261Trial NCT00520767Trial NCT00514215Trial NCT00503841Trial NCT00499694Trial NCT00482846Trial NCT00459121Trial NCT00438204Trial NCT00423826Trial NCT00410904Trial NCT00376948Trial NCT00369109Trial NCT00305747Trial NCT00303901Trial NCT00301808Trial NCT00293384Trial NCT00288028Trial NCT00258466Trial NCT00258310Trial NCT00258284Trial NCT00258245Trial NCT00258232Trial NCT00248560Trial NCT00248482Trial NCT00244946Trial NCT00244933Trial NCT00243048Trial NCT00238329Trial NCT00227721Trial NCT00217581Trial NCT00121264Trial NCT00118157Trial NCT00078923Trial NCT00068653Trial NCT00066326Trial NCT00056004

Abstract

Cancer is the second leading cause of death in the state of Michigan. However, expected cancer mortality in 2020 may be underestimated due to the COVID-19 pandemic. The pandemic is a public health crisis that has dramatically altered almost every dimension of daily life in the U.S. Michigan ranks fifth among states in COVID-19 incidence and mortality, largely driven by the predominantly African American city of Detroit, which accounts for one-third of Michigan?s COVID-19 cases. COVID-19-related disruptions in daily life and routines may have a broad range of adverse consequences including limited access to care, resources, and information, as well as psychological distress that undermine prevention and control efforts at the population and individual level and across the cancer care continuum. Therefore, we propose to participate in a consortium of NCI-designated cancer centers who will rapidly deploy surveys containing a standard set of core questions to populations across the U.S. The broad goal of the proposed research is to assess how differences in demographics (rural/urban, age, gender, race, educational attainment) will impact engagement in cancer preventive behaviors (e.g., tobacco cessation) and cancer management/survivorship behaviors (e.g., adherence to treatment and surveillance) in the context of COVID19-related environmental constraints (e.g., social distancing, employment, mental health, etc.). This research will be conducted among the general adult population, cancer patients, and cancer survivors within Karmanos Cancer Institute?s 46-county catchment area in Michigan. Further, this work will be aligned with the efforts of a COVID-19 Population Science (CPS) Consortium that includes University of Iowa Holden Comprehensive Cancer Center, the James Comprehensive Cancer Center at the Ohio State University, University of Colorado Cancer Center, and the O?Neal Comprehensive Cancer Center at University of Alabama ? Birmingham as the coordinating site. There are three specific aims. Aim 1: Develop a core set of questions to assess community and individual responses to the COVID-19 pandemic across populations, along with modules that will apply to specific sub-populations in any given catchment area. Aim 2: Administer the core set of questions and locally relevant modules to 2000 adults to determine the association between COVID-19 responses and cancer prevention and control behaviors among the general adult population, cancer patients, and cancer survivors in the KCI catchment area in Michigan, with a focus on racial and rural-urban differences. Aim 3: Develop and implement strategies to increase access to appropriate cancer resources based on survey results, in partnership with stakeholder organizations throughout the catchment area and evaluate their reach in the population. The proposed work represents an extraordinary opportunity to capture the impact of this public health crisis on cancer care and outcomes. This research will also shed new light on the social determinants that drive racial disparities in cancer specifically, and health more broadly. Data will also inform practical strategies to support vulnerable populations that disproportionately carry COVID-19 burden.

View original record on NIH RePORTER →